10250-61-0 Usage
Description
METHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE is an organic compound belonging to the pyrazole family. It is characterized by its unique chemical structure, which features a pyrazole ring with a carboxylate group and two methyl groups attached to the adjacent carbon atoms. METHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE is of interest in various scientific and industrial applications due to its distinct properties and reactivity.
Uses
Used in Chemical Research:
METHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE is used as a research compound for studying proton magnetic resonance (NMR) of pyrazoles. Its unique structure allows researchers to investigate the magnetic properties of the pyrazole ring and its substituents, which can provide valuable insights into the behavior of similar compounds and their potential applications in various fields.
Used in Pharmaceutical Industry:
METHYL 1,5-DIMETHYL-1H-PYRAZOLE-3-CARBOXYLATE may be used as a building block or intermediate in the synthesis of various pharmaceutical compounds. Its reactivity and structural features make it a promising candidate for the development of new drugs with potential therapeutic applications.
Used in Material Science:
The compound may also find applications in the field of material science, where its unique properties can be exploited to develop new materials with specific characteristics. For example, it could be used to create novel polymers or other materials with tailored properties for various industrial applications.
Check Digit Verification of cas no
The CAS Registry Mumber 10250-61-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,5 and 0 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 10250-61:
(7*1)+(6*0)+(5*2)+(4*5)+(3*0)+(2*6)+(1*1)=50
50 % 10 = 0
So 10250-61-0 is a valid CAS Registry Number.
InChI:InChI=1/C7H10N2O2/c1-5-4-6(7(10)11-3)8-9(5)2/h4H,1-3H3
10250-61-0Relevant articles and documents
Novel alpha-cyano-beta-oxopropionamides
-
, (2008/06/13)
α-(Substituted carbamoyl)-β-aryl- and heteroaryl-β-oxo-propionitriles of formula, , A-CO- enol ethers thereof and salts thereof, as well as pharmaceutical preparations containing same and methods of preparing and using these compounds are disclosed. Said compounds represent novel antiinflammatory and antirheumatic agents. Their property to interfere with both the cyclooxygenase and lipoxygenase pathway of the arachidonic fatty acid bioconversion to inflammatory mediators make them valuable therapeutics. These properties render the mentioned substituted carbamoyl-β-oxopropionitriles useful for the treatment of arthritic and rheumatic diseases and other inflammatory conditions in mammals.
